Danaher (DHR) Market Capitalization, Earnings, Price, Holders
Symbol: DHR Rank: #59 Price: $242.26(-1.34789%)

Market Cap: $178.7B($-2.4B) Industry: Diagnostics & Research Sector: Healthcare Country: United States Insiders: 10.95% Institutions: 80.649%
Danaher Corporation Technicals

52 Week High: $303.24

52 Week Low: $233.03

50 Day MA: $261.55

200 Day MA: $264.95

52 Week Trading Range


Low: $233.03

High: $303.24

Daily Trading Range


Low: $241.955

High: $245.51

Market capitalization history for Danaher (DHR) in USD

As of November 2023, Danaher (DHR) has a market cap of $178.7 billion. Our data points out that DHR is ranked #59 in the world. A company's market capitalization is the present value of all of its outstanding shares, and it is commonly used to give a sense of how much the stock of a company would be worth at today's exchange rates. DHR's market cap is -1.34789% down from the last trading day.

DHR Statistics

Market Cap
Revenue TTM
Gross Profit TTM
Operating Margin TTM
Shares Outstanding
Shares Float
Trading Volume
P/E Ratio
PEG Ratio
Revenue Per Share
Dividend Per Share
Dividend Yield
Quote Type
Leaf logo
CDP Climate Change Score (DHR)

Latest News

Danaher (DHR) Shares Stats
Danaher (DHR) Valuation
Trailing P/E $25.8252
Forward P/E $25.9067
Price Sales TTM $6.2915
Price Book MRQ $4.3266
Enterprise Value $211,834,474,156
Enterprise Value Revenue $6.7787
Enterprise Value Ebitda $19.9261
Danaher Corporation Details

Address: 2200 Pennsylvania Avenue, NW

City: Washington

Zip: 20037-1701

Phone: 202 828 0850

Website: https://www.danaher.com

IPO Date: 1979-01-05

CEO: Steven M. Rales

Employees: 78,000

What is DHR about?

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.